Login
Navigate Fool.com
Will TTHI beat
the market?
Community Rating: 2 Stars: Unattractive

5.59 0.05 (0.90%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.54
Previous Close $5.54
Daily Range $5.31 - $5.67
52-Week Range $1.93 - $8.22
Market Cap $165.9M
P/E Ratio -19.28
Dividend (Yield) $0.00 (0.0%)
Volume 82,674
Average Daily Volume 79,440
Current FY EPS -$0.43

How do you think TTHI
will perform against the market?

Top TTHI Bull/Bear Pitches

 

Option1307 (< 20)
Submitted December 20, 2009

I've done very little research here, just guessing that the recent dop is unwarranted.

0 Replies Reply Report this Post
 

TMFUltraLong (< 20)
Submitted February 22, 2011

Didn't I bash Transition Therapeutics before? These micro cap biotechs all start looking alike when they have only one or two drugs in the works and a boatload of cash they're burning through. <br />< … More

1 Replies Reply Report this Post

News & Commentary

3 Stocks Near 52-Week Highs Worth Selling

Are these three stocks sells or belles? You be the judge!

Tuesday Sector Laggards: Biotechnology, Drugs

After-Hours Earnings Report for September 11, 2013 : MW, VRA, EPM, TTHI, CEDU

After-Hours Earnings Report for September 11, 2013 : MW, VRA, EPM, TTHI, CEDU

Is Elan Pushing Its Luck?

Eli Lilly to Take Over Development of Diabetes Drug

Eli Lilly to pay Transition Therapeutics $7 million initially for the drug being developed to treat type 2 diabetes and accompanying obesity.

Transition to Get $7 Million as Lilly to Assume Rights to TT-401

U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

Elan, Lonza in Supply Deal - Analyst Blog

UPDATE: Transition Halts Development Of Lead Diabetes Drug

Transition Halts Development Of Lead Diabetes Candidate

See More TTHI News...

Sector

Healthcare

Industry

Drugs

Transition Therapeutics Inc. (TTHI) Description

Transition Therapeutics Inc. (Transition) is a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets. Website: http://www.transitiontherapeutics.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks